GIAMPIETRO, Letizia
 Distribuzione geografica
Continente #
NA - Nord America 5.293
EU - Europa 3.731
AS - Asia 3.591
SA - Sud America 348
AF - Africa 64
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 13.033
Nazione #
US - Stati Uniti d'America 5.144
SG - Singapore 1.370
CN - Cina 977
IT - Italia 869
IE - Irlanda 461
TR - Turchia 449
UA - Ucraina 416
SE - Svezia 395
RU - Federazione Russa 328
GB - Regno Unito 318
VN - Vietnam 312
BR - Brasile 286
FR - Francia 283
IN - India 254
DE - Germania 219
PL - Polonia 129
FI - Finlandia 118
CA - Canada 105
HK - Hong Kong 43
ES - Italia 40
JP - Giappone 34
AT - Austria 30
MX - Messico 29
BD - Bangladesh 25
ZA - Sudafrica 24
BE - Belgio 23
CZ - Repubblica Ceca 23
LT - Lituania 22
PK - Pakistan 20
NL - Olanda 19
AR - Argentina 16
KR - Corea 15
IQ - Iraq 14
VE - Venezuela 13
CL - Cile 10
ID - Indonesia 9
SA - Arabia Saudita 9
AE - Emirati Arabi Uniti 8
CO - Colombia 8
DZ - Algeria 8
MA - Marocco 8
GR - Grecia 7
PH - Filippine 7
PT - Portogallo 7
EC - Ecuador 6
IL - Israele 6
KE - Kenya 6
TW - Taiwan 6
EG - Egitto 5
ET - Etiopia 5
HR - Croazia 5
AU - Australia 4
CH - Svizzera 4
IR - Iran 4
JM - Giamaica 4
JO - Giordania 4
MY - Malesia 4
PE - Perù 4
AL - Albania 3
BG - Bulgaria 3
CR - Costa Rica 3
NP - Nepal 3
TT - Trinidad e Tobago 3
YE - Yemen 3
AZ - Azerbaigian 2
EE - Estonia 2
LB - Libano 2
PA - Panama 2
PY - Paraguay 2
SN - Senegal 2
TN - Tunisia 2
UY - Uruguay 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
DK - Danimarca 1
EU - Europa 1
GD - Grenada 1
GY - Guiana 1
HU - Ungheria 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
MM - Myanmar 1
MT - Malta 1
OM - Oman 1
PR - Porto Rico 1
QA - Qatar 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SO - Somalia 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
ZW - Zimbabwe 1
Totale 13.033
Città #
Singapore 1.046
Chandler 591
San Jose 547
Jacksonville 500
Dublin 455
Ashburn 440
Izmir 286
Dearborn 243
Beijing 238
Chieti 228
Dallas 218
Southend 196
Princeton 187
Nanjing 146
Los Angeles 126
The Dalles 123
Ann Arbor 121
Ho Chi Minh City 109
Santa Clara 109
Cambridge 103
Wilmington 93
Kraków 92
New York 68
Hanoi 67
Nanchang 67
Altamura 57
Tongling 56
Buffalo 47
Boardman 44
Moscow 40
São Paulo 40
Hong Kong 37
Houston 37
Munich 37
Hebei 35
Council Bluffs 34
Warsaw 34
Teramo 32
Woodbridge 32
Orem 31
Tianjin 31
Toronto 31
Jiaxing 30
Kocaeli 30
Kunming 30
Pescara 30
Denver 28
Hefei 28
Helsinki 28
Bosa 27
Redondo Beach 27
Tokyo 27
Brooklyn 26
Shenyang 26
Atlanta 25
Jinan 25
Changsha 24
Ottawa 24
Washington 24
Brussels 23
Montreal 22
Vienna 22
Chennai 21
Milan 21
Brno 20
London 20
Poplar 19
Bologna 18
Da Nang 18
Stockholm 18
Johannesburg 17
Rome 17
Haiphong 15
Hangzhou 15
Norwalk 15
Turku 15
Frankfurt am Main 14
Ningbo 14
Chicago 13
Mumbai 13
Augusta 12
Amsterdam 11
Redwood City 11
Seattle 11
Seoul 11
Ankara 10
Dong Ket 10
Nuremberg 10
Orange 10
San Francisco 10
Mexico City 9
San Mateo 9
San Vito Chietino 9
Auburn Hills 8
Como 8
Guangzhou 8
New Delhi 8
Phoenix 8
Rio de Janeiro 8
Shanghai 8
Totale 8.072
Nome #
Synthesis of 2-aryloxypropanoic acids analogues of clofibric acid and assignment of the absolute configuration by 1H NMR spectroscopy and DFT calculations 189
Anticancer Activity of Stilbene-Based Derivatives 189
Discovery of N-{3-[(ethanimidoylamino)methyl]benzyl}-L-prolinamide dihydrochloride: A new potent and selective inhibitor of the inducible nitric oxide synthase as a promising agent for the therapy of malignant glioma 187
Synthesis and antibacterial evaluation of oxazolidin-2-ones structurally related to linezolid 186
Synthesis of fibrates analogues and pharmacological evaluation as PPARa agonists 182
Progettazione e sintesi di ossazolidinoni a potenziale attività antibatterica 176
Valutazione biologica dei derivati dell'acido clofibrico come potenziali ligandi PPARs 176
Amidine N-sostituite come potenziali inibitori delle Ossido Nitrico Sintasi 173
Synthesis, biological activity, and docking studies of novel acetamidines as selective modulators of nitric oxide synthase 168
Titanium-Promoted Acylation of Sulfonamides to N-Acylsulfonamide PPAR Antagonists 168
Synthesis and structure-activity relationships of fibrate-based analogues inside PPARs 166
Synthesis and Biological Evaluation of 2-Heteroarylthioalkanoic Acid Analogues of Clofibric Acid as Peroxisome Proliferator-Activated Receptor alfa Agonists 165
Asymmetric synthesis of (S)-ibuprofen by esterification with amides of (S)-lactic acid as chiral auxiliaries: experimental and theoretical results 164
Synthesis and biological evaluation of potential Nitric Oxide Synthase inhibitors 161
Novel Phenyldiazenyl Fibrate Analogues as PPAR α/γ/δ Pan-Agonists for the Amelioration of Metabolic Syndrome 159
Determinazione della configurazione assoluta di acidi carbossilici a-sostituiti di interesse farmaceutico attraverso spettroscopia NMR 158
Antiglioma Activity of Aryl and Amido-Aryl Acetamidine Derivatives Targeting iNOS: Synthesis and Biological Evaluation 158
Discovery of new FXR agonists based on 6-ECDCA binding properties by virtual screening and molecular docking 157
Cytotoxic effect of a family of Peroxisome Proliferator-Activated Receptor antagonists in colorectal and pancreatic cancer cell lines 156
Asymmetric Synthesis of Arylpropionic Acids and Aryloxy Acids by Using Lactamides as Chiral Auxiliaries 155
Benzothiazole-based N-(phenylsulfonyl)amides as a novel familyof PPARa antagonists 155
Synthesis of benzothiazolyl-thioalkanoic acids and pharmacological evaluation on PPARa 154
Candida rugosa lipase-catalysed kinetic resolution of 2-substituted-aryloxyacetic esters with dimethylsulfoxide and isopropanol as additives 154
Anti-Inflammatory, Antioxidant, and WAT/BAT-Conversion Stimulation Induced by Novel PPAR Ligands: Results from Ex Vivo and In Vitro Studies 153
Blocking the Peroxisome Proliferator-Activated Receptor (PPAR): An Overview 153
Development of a Rapid Mass Spectrometric Determination of AMP and Cyclic AMP for PDE3 Activity Study: Application and Computational Analysis for Evaluating the Effect of a Novel 2-oxo-1,2-dihydropyridine-3-carbonitrile Derivative as PDE-3 Inhibitor 153
Sintesi ed attività antibatterica di 3-cinnamoil e 3-piridinilossazolidin -2-oni 149
Synthesis and biological evaluation of gemfibrozil chiral analogs as potential PPARa agonists 148
Druggability profile of stilbene-derived PPAR agonists: Determination of physicochemical properties and PAMPA study 148
Enantiomeric separation of Gemfibrozil chiral analogues by capillary electrophoresis with heptakis(2,3,6-tri-O-methyl)-beta-cyclodextrin as chiral selector 146
The Selective Acetamidine-Based iNOS Inhibitor CM544 Reduces Glioma Cell Proliferation by Enhancing PARP-1 Cleavage In Vitro 146
PPARα agonists based on stilbene and its bioisosteres: Biological evaluation and docking studies 145
Synthesis and biological characterization of 3-(imidazol-1-ylmethyl)piperidine sulfonamides as aromatase inhibitors 145
Syntesis and pharmacological evaluation of fibrates analogues as cardiovascular agents 144
Fibrate-derived N-(methylsulfonyl)amides with antagonistic properties on PPARa 143
Synthesis and antiplatelet activity of thioaryloxyacids analogues of clofibric acid 142
Synthesis and cytotoxic effects on pancreatic cancer cells of resveratrol analogs 140
Synthesis and antiplatelet activity of clofibric acid analogues 139
Synthesis, biological evaluation and docking studies of N-substituted acetamidines as selective inhibitors of inducible nitric oxide synthase 139
Sintesi e valutazione biologica di analoghi eterociclici del gemfibrozil a potenziale attività cardiovascolare 139
Indazole, Pyrazole, and Oxazole Derivatives Targeting Nitric Oxide Synthases and Carbonic Anhydrases 136
Sulfonimide and Amide Derivatives as Novel PPARα Antagonists: Synthesis, Antiproliferative Activity, and Docking Studies 136
N-acylsulfonamides: synthetic routes and biological potential in medicinal chemistry 135
Synthesis and biological evaluation of new acetamidines as selective inhibitors of Nitric Oxide Synthases 134
Synthesis of naphthyl-, quinolin- and anthracenyl analogues of clofibric acid as PPARα agonists 134
Selective Acetamidine-Based Nitric Oxide Synthase Inhibitors: Synthesis, Docking, and Biological Studies 132
Sintesi di analoghi chirali del gemfibrozil 2,5,disostituiti a potenziale attività antiaggregante piastrinica 130
Selective inhibition of inducible Nitric Oxide Synthase by derivatives of acetamidine 129
Starting a new series of acetamidines as Nitric Oxide Sinthase inhibitors 129
Fibrate-based N-acylsulphonamides targeting carbonic anhydrases: synthesis, biochemical evaluation, and docking studies 129
Discovery of gemfibrozil analogues that activate PPARa and enhance the expression of gene CPT1A involved in fatty acids catabolism 128
null 128
Analoghi eterociclici dell’acido clofibrico: sintesi, attività antiaggregante piastrinica e separazione in elettroforesi capillare 127
Synthesis, characterization and evaluation of gemfibrozil-stilbene hybrid as antioxidant agent 127
Dynamic kinetic resolution of α-bromoesters containing lactamides as chiral auxiliaries 126
Structural development studies of PPARs ligands based on tyrosine scaffold 126
Dual-PPAR agonists based on stilbene scaffold: synthesis and biological evaluation 124
Benzothiazole Derivatives Endowed with Antiproliferative Activity in Paraganglioma and Pancreatic Cancer Cells: Structure-Activity Relationship Studies and Target Prediction Analysis 123
Selective Inhibition of iNOS by Benzyl- and Dibenzyl Derivatives of N-(3-Aminobenzyl)acetamidine. 123
N-Substituted acetamidines and 2-methylimidazole derivatives as selective inhibitors of neuronal nitric oxide synthase 122
Sintesi di esteri del gemfibrozil donatori di ossido nitrico 120
Platelet aggregation: synthesis and pharmacological evaluation of clofibric acid analogues 119
Development of Fibrates as Important Scaffolds in Medicinal Chemistry 119
Effect of milrinone analogues on intracellular calcium increase on single living H9C2 cells 118
Selective inhibition of iNOS by benzyl- and dibenzyl derivatives of N-(3-aminobenzyl)acetamidine on cellular line H2C9 117
Synthesis and cytotoxicity evaluation of novel amide and sulfonimide PPARa antagonists 117
PPAR-γ agonist GL516 reduces oxidative stress and apoptosis occurrence in a rat astrocyte cell line 116
Synthesis, biological evaluation and molecular modelling of new PPARa agonists 115
Effect of stilbene and chalcone scaffolds incorporation in clofibric acid on PPARα agonistic activity 115
Synthetic strategies for lysine-proline chimeras: an overview 114
PPARα as Potential Therapeutic Target for Neurodegenerative Diseases 112
Effect of milrinone analogues on intracellular calcium increase in single living H9C2 cardiac cells 111
Novel Phenyldiazenyl Fibrate Analogues as PPAR Agonists: Design, Synthesis and Pharmacological Evaluation 110
Design, synthesis and biological evaluation of imidazole and triazole-based carbamates as novel aromatase inhibitors 110
Sintesi di derivati eterociclici dell’acido clofibrico a potenziale attività antiaggregante piastrinica 109
Synthesis, biological evaluation, and docking study of indole aryl sulfonamides as aromatase inhibitors 109
Identification of new anti-Candida compounds by ligand-based pharmacophore virtual screening 108
In vitro protective effects of resveratrol and stilbene alkanoic derivatives on induced oxidative stress on c2c12 and mcf7 cells 107
Design, synthesis and biological evaluation of aromatase inhibitors based on sulfonates and sulfonamides of resveratrol 107
Synthesis of novel benzothiazole amides: Evaluation of PPAR activity and anti-proliferative effects in paraganglioma, pancreatic and colorectal cancer cell lines 107
Capillary electrophoretic enantioseparation of gemfibrozil analogues by use of TM-b-cyclodextrin as chiral selector 105
Synthesis and pharmacological evaluation of gemfibrozil chiral analogues as cardiovascular agents 105
Synthesis, structure-activity relationships and molecular docking studies of phenyldiazenyl sulfonamides as aromatase inhibitors 103
Methods to Evaluate the Activity of Nitric Oxide Synthase 102
Reversed-phase high-performance liquid chromatography method with fluorescence detection to screen nitric oxide synthases inhibitors. 102
Fibrate-Based Analogues as PPARs Agonists: Synthesis and Structure–Activity Relationships 101
PPAR Ligands Containing Stilbene Scaffold 101
QSAR, QSPR and QSRR in terms of 3-D-MoRSE descriptors for in silico screening of clofibric acid analogues 100
Azobenzenesulfonamide Carbonic Anhydrase Inhibitors as New Weapons to Fight Helicobacter pylori: Synthesis, Bioactivity Evaluation, In Vivo Toxicity, and Computational Studies 99
Screening of NOS activity and selectivity of newly synthesized acetamidines using RP-HPLC 96
Synthesis and Biological Evaluation of Halogenated E-Stilbenols as Promising Antiaging Agents 95
Stilbene derivatives as new perspective in antifungal medicinal chemistry 95
Synthetic Approach to Phenylalanine-Proline, and Tyrosine-Proline Hybrid Amino Acids 93
In vitro evaluation of a new selective iNOS inhibitor on normal rat astrocytes and C6 rat glioma cells 93
Azobenzene as Multi-Targeted Scaffold in Medicinal Chemistry 92
N-Acylsulfonylamides as a new class of PPARa antagonists 91
Sintesi, relazioni struttura-attività e docking di nuovi inibitori delle Ossido Nitrico Sintasi 90
Geometric Isomerism of an Acetamidino Derivative Determined by NMR Investigations 88
A novel life for antitumor combretastatins: Recent developments of hybrids, prodrugs, combination therapies, and antibody-drug conjugates 85
Different binding and recognition modes of GL479, a dual agonist of Peroxisome Proliferator-Activated Receptor α/γ 85
Totale 13.087
Categoria #
all - tutte 47.882
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.882


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021153 0 0 0 0 0 0 0 0 0 93 10 50
2021/2022610 13 9 20 94 52 17 21 42 92 21 75 154
2022/20231.670 124 233 120 167 155 321 79 132 217 20 54 48
2023/2024771 61 32 58 21 49 231 193 10 7 27 6 76
2024/20251.894 72 341 338 46 38 94 73 97 174 99 256 266
2025/20263.998 338 154 394 574 517 263 783 271 424 280 0 0
Totale 13.593